Is definitive concurrent chemoradiotherapy effective for locally advanced head and neck cancer in the elderly aged ≥ 75 years: A single-institute, retrospective, cohort study.

about

Is definitive concurrent chemoradiotherapy effective for locally advanced head and neck cancer in the elderly aged ≥ 75 years: A single-institute, retrospective, cohort study.

Item

http://www.wikidata.org/entity/Q47288168

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Is definitive concurrent chemo ...... , retrospective, cohort study.

@en

Is definitive concurrent chemo ...... , retrospective, cohort study.

@nl

type

Item

label

Is definitive concurrent chemo ...... , retrospective, cohort study.

@en

Is definitive concurrent chemo ...... , retrospective, cohort study.

@nl

prefLabel

Is definitive concurrent chemo ...... , retrospective, cohort study.

@en

Is definitive concurrent chemo ...... , retrospective, cohort study.

@nl

P1476

Is definitive concurrent chemo ...... e, retrospective, cohort study

@en

P2093

Chia-Chun Liang

http://www.w3.org/2001/XMLSchema#string

Hsueh-Ju Lu

http://www.w3.org/2001/XMLSchema#string

Jen-Tsun Lin

http://www.w3.org/2001/XMLSchema#string

Mu-Kuan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or ..

Cancer statistics, 2009

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.

Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis.

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.

Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases.

Treatment of head and neck cancer in elderly patients: state of the art and guidelines.

Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

P304

247-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12764

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kuan-Ming Lai

P577

2017-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28840980

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy